BIMEKIZUMAB: The First Dual Inhibitor of Interleukin (Il)-17A and Il-17F for the Treatment of Psoriatic Disease and Ankylosing Spondylitis
AuthID
P-00Q-PV1
P-00Q-PV1
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service